Cannabinoids for Agitation in Alzheimer's Disease.

导出 OA

翻译打印收藏纠错

作者： John D,Outen ^[1] ; M Haroon,Burhanullah ^[1] ; Ryan,Vandrey ^[2] ; Halima,Amjad ^[3] ; David G,Harper ^[4] ; Regan E,Patrick ^[4] ; Rose L,May ^[5] ; Marc E,Agronin ^[6] ; Brent P,Forester ^[4] ; Paul B,Rosenberg ^[7]

作者单位： Department of Psychiatry & Behavioral Sciences (JDO, HB, PBR), Johns Hopkins University School of Medicine, Baltimore, MD. ^[1] Behavioral Pharmacology Research (RV), Johns Hopkins University School of Medicine, Baltimore, MD. ^[2] Geriatric Medicine and Gerontology (HA), Johns Hopkins University School of Medicine, Baltimore, MD. ^[3] Division of Geriatric Psychiatry (DGH, REP, RLM, BPF), McLean Hospital, Belmont, MA; Department of Psychiatry (DGH, REP, BPF), Harvard Medical School, Boston, MA. ^[4] Division of Geriatric Psychiatry (DGH, REP, RLM, BPF), McLean Hospital, Belmont, MA. ^[5] Department of Mental Health and Clinical Research (MEA), Miami Jewish Health, Miami, FL. ^[6] Department of Psychiatry & Behavioral Sciences (JDO, HB, PBR), Johns Hopkins University School of Medicine, Baltimore, MD. Electronic address: prosenb9@jhmi.edu. ^[7]

关键词 Alzheimer's disease CBD THC aggression agitation cannabinoids dementia mechanisms neuropsychiatric symptoms

主题词阿尔茨海默病(Alzheimer Disease);大麻酚类(Cannabinoids);额叶(Frontal Lobe);人类(Humans);精神运动性激动(Psychomotor Agitation);生活质量(Quality of Life)

DOI 10.1016/j.jagp.2021.01.015

PMID 33573996

发布时间 2022-12-02

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交